US regulators approve 2nd gene therapy for blood cancer
The Food and Drug Administration on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphomas.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Gene Therapy | Genetics | Health | Lymphoma